Literature DB >> 16038952

Polar acyclic diterpenoids from Bifurcaria bifurcata (Fucales, Phaeophyta).

Annick Ortalo-Magné1, Gérald Culioli, Robert Valls, Bernard Pucci, Louis Piovetti.   

Abstract

From the lipophilic extract of the brown alga Bifurcaria bifurcata collected off the Atlantic coast of Southern Brittany (Quiberon, France), five polar linear diterpenoids have been isolated. These metabolites have been identified as hydroxylated derivatives of 13-oxo- and 13-hydroxygeranylgeraniol. Their structures were characterized on the basis of chemical and spectral evidence including two-dimensional NMR experiments and mass spectrometric techniques. The absolute configuration of the 13-position has been determined, for the 13-hydroxygeranylgeraniol derivatives, to be R by means of a modified Mosher's method and therefore that of 13-hydroxygeranylgeraniol (eleganediol) has been revised. Along with these compounds, three related known geranylgeraniol derivatives were also identified, and these data were used for chemotaxonomical purposes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16038952     DOI: 10.1016/j.phytochem.2005.06.006

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  8 in total

1.  Antiprotozoal activities of organic extracts from French marine seaweeds.

Authors:  Catherine Vonthron-Sénécheau; Marcel Kaiser; Isabelle Devambez; Antoine Vastel; Isabelle Mussio; Anne-Marie Rusig
Journal:  Mar Drugs       Date:  2011-05-25       Impact factor: 6.085

2.  Antioxidant and Neuroprotective Potential of the Brown Seaweed Bifurcaria bifurcata in an in vitro Parkinson's Disease Model.

Authors:  Joana Silva; Celso Alves; Rafaela Freitas; Alice Martins; Susete Pinteus; Joana Ribeiro; Helena Gaspar; Amparo Alfonso; Rui Pedrosa
Journal:  Mar Drugs       Date:  2019-02-01       Impact factor: 5.118

Review 3.  Current Research on the Bioprospection of Linear Diterpenes from Bifurcaria bifurcata: From Extraction Methodologies to Possible Applications.

Authors:  Adriana C S Pais; Jorge A Saraiva; Sílvia M Rocha; Armando J D Silvestre; Sónia A O Santos
Journal:  Mar Drugs       Date:  2019-09-28       Impact factor: 5.118

4.  Oxygenated Acyclic Diterpenes with Anticancer Activity from the Irish Brown Seaweed Bifurcaria bifurcata.

Authors:  Vangelis Smyrniotopoulos; Christian Merten; Daria Firsova; Howard Fearnhead; Deniz Tasdemir
Journal:  Mar Drugs       Date:  2020-11-23       Impact factor: 5.118

5.  High pressure extraction of bioactive diterpenes from the macroalgae Bifurcaria bifurcata: an efficient and environmentally friendly approach.

Authors:  Adriana C S Pais; Carlos A Pinto; Patrícia A B Ramos; Ricardo J B Pinto; Daniela Rosa; Maria F Duarte; M Helena Abreu; Silvia M Rocha; Jorge A Saraiva; Armando J D Silvestre; Sónia A O Santos
Journal:  RSC Adv       Date:  2019-12-02       Impact factor: 3.361

6.  Eleganolone, a diterpene from the French marine alga Bifurcaria bifurcata inhibits growth of the human pathogens Trypanosoma brucei and Plasmodium falciparum.

Authors:  Jean-Baptiste Gallé; Barthélémy Attioua; Marcel Kaiser; Anne-Marie Rusig; Annelise Lobstein; Catherine Vonthron-Sénécheau
Journal:  Mar Drugs       Date:  2013-02-26       Impact factor: 5.118

Review 7.  Marine Algae as Source of Novel Antileishmanial Drugs: A Review.

Authors:  Lauve Rachel Tchokouaha Yamthe; Regina Appiah-Opong; Patrick Valere Tsouh Fokou; Nole Tsabang; Fabrice Fekam Boyom; Alexander Kwadwo Nyarko; Michael David Wilson
Journal:  Mar Drugs       Date:  2017-10-29       Impact factor: 5.118

8.  Lipophilic Fraction of Cultivated Bifurcaria bifurcata R. Ross: Detailed Composition and In Vitro Prospection of Current Challenging Bioactive Properties.

Authors:  Sónia A O Santos; Stephanie S Trindade; Catia S D Oliveira; Paula Parreira; Daniela Rosa; Maria F Duarte; Isabel Ferreira; Maria T Cruz; Andreia M Rego; Maria H Abreu; Silvia M Rocha; Armando J D Silvestre
Journal:  Mar Drugs       Date:  2017-11-01       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.